Future Prospects And Stock Pricing Of Conduit Pharmaceuticals Inc (NASDAQ: CDT)

In today’s recent session, 1.57 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) have been traded, and its beta is 2.09. Most recently the company’s share price was $0.11, and it changed around $0.0 or -1.43% from the last close, which brings the market valuation of the company to $10.61M. CDT at last check was trading at a discount to its 52-week high of $7.83, offering almost -7018.18% off that amount. The share price’s 52-week low was $0.09, which indicates that the recent value has risen by an impressive 18.18% since then. We note from Conduit Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 22.98 million shares, with the 3-month average coming to 19.31 million.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT has been showing red trend so far today with a performance of -1.43% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.1400 on recent trading dayincreased the stock’s daily price by 21.43%. The company’s shares are currently down -97.57% year-to-date, but still up 4.05% over the last five days. On the other hand, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -11.88% down in the 30-day period. We can see from the shorts that 1.45 million shares have been sold at a short interest cover period of 0.25 day(s).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CDT Dividends

Conduit Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in November.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 54.98% of Conduit Pharmaceuticals Inc shares, and 3.07% of them are in the hands of institutional investors. The stock currently has a share float of 6.81%.

Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jul 31, 2024. The former held 234.14 shares worth $25755.0, making up 0.23% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 202.93 shares worth around $22322.0, which represents about 0.20% of the total shares outstanding.